PolyPeptide Laboratories (Sweden) AB
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Sweden
- Registered address
- Hogerudsgatan 21, Limhamn, - SE-21613, Sweden (SWE)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3002807004 · DUNS 356580779
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-01-23
- VAIDrug Quality Assurance2019-04-10
- NAIDrug Quality Assurance2016-05-27
- VAIDrug Quality Assurance2013-09-20
- NAIDrug Quality Assurance2009-10-07
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- Desmopressin Acetatein shortageFerring Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.